Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival
Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BA...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 109; no. 38; pp. 15401 - 15406 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
18.09.2012
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell–independent antibody responses. Here we demonstrate that Taci-/- mice have expanded populations of T follicular helper (Tfh) and germinal center (GC) B cells in their spleens when immunized with T-cell–dependent antigen. The increased numbers of Tfh and GC B cells in Taci-/- mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the Icosl allele restores normal levels of Tfh and GC B cells in Taci-/- mice. Interestingly, despite the presence of increased Tfh and antigen-specific B cells, immunized Taci-/- mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in Taci-/- plasma cells. Ablation of BIM could rescue ASC formation in Taci-/- mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of Tfh and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. |
---|---|
AbstractList | Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell–independent antibody responses. Here we demonstrate that
Taci
−/−
mice have expanded populations of T follicular helper (T
fh
) and germinal center (GC) B cells in their spleens when immunized with T-cell–dependent antigen. The increased numbers of T
fh
and GC B cells in
Taci
−/−
mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the
Icosl
allele restores normal levels of T
fh
and GC B cells in
Taci
−/−
mice. Interestingly, despite the presence of increased T
fh
and antigen-specific B cells, immunized
Taci
−/−
mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in
Taci
−/−
plasma cells. Ablation of BIM could rescue ASC formation in
Taci
−/−
mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of T
fh
and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell-independent antibody responses. Here we demonstrate that Taci(-/-) mice have expanded populations of T follicular helper (T(fh)) and germinal center (GC) B cells in their spleens when immunized with T-cell-dependent antigen. The increased numbers of T(fh) and GC B cells in Taci(-/-) mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the Icosl allele restores normal levels of T(fh) and GC B cells in Taci(-/-) mice. Interestingly, despite the presence of increased T(fh) and antigen-specific B cells, immunized Taci(-/-) mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in Taci(-/-) plasma cells. Ablation of BIM could rescue ASC formation in Taci(-/-) mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of T(fh) and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell–independent antibody responses. Here we demonstrate that Taci-/- mice have expanded populations of T follicular helper (Tfh) and germinal center (GC) B cells in their spleens when immunized with T-cell–dependent antigen. The increased numbers of Tfh and GC B cells in Taci-/- mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the Icosl allele restores normal levels of Tfh and GC B cells in Taci-/- mice. Interestingly, despite the presence of increased Tfh and antigen-specific B cells, immunized Taci-/- mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in Taci-/- plasma cells. Ablation of BIM could rescue ASC formation in Taci-/- mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of Tfh and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell-independent antibody responses. Here we demonstrate that Taci... mice have expanded populations of T follicular helper (T...) and germinal center (GC) B cells in their spleens when immunized with T-cell-dependent antigen. The increased numbers of T... and GC B cells in Taci... mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the Icosl allele restores normal levels of Tfh and GC B cells in Taci... mice. Interestingly, despite the presence of increased Tfh and antigen-specific B cells, immunized Taci... mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in Taci... plasma cells. Ablation of BIM could rescue ASC formation in Taci... mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of Tfh and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. (ProQuest: ... denotes formulae/symbols omitted.) Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in humans. How TACI regulates these two opposing conditions is unclear, however. TACI binds the cytokines BAFF and APRIL, and previous studies using gene KO mice indicated that loss of TACI affected only T-cell–independent antibody responses. Here we demonstrate that Taci −/− mice have expanded populations of T follicular helper (T fh ) and germinal center (GC) B cells in their spleens when immunized with T-cell–dependent antigen. The increased numbers of T fh and GC B cells in Taci −/− mice are largely a result of up-regulation of inducible costimulator (ICOS) ligand on TACI-deficient B cells, given that ablation of one copy of the Icosl allele restores normal levels of T fh and GC B cells in Taci −/− mice. Interestingly, despite the presence of increased T fh and antigen-specific B cells, immunized Taci −/− mice demonstrate defective antigen-specific antibody responses resulting from significantly reduced numbers of antibody-secreting cells (ASCs). This effect is attributed to the failure to down-regulate the proapoptotic molecule BIM in Taci −/− plasma cells. Ablation of BIM could rescue ASC formation in Taci −/− mice, suggesting that TACI is more important for the survival of plasma cells than for the differentiation of these cells. Thus, our data reveal dual roles for TACI in B-cell terminal differentiation. On one hand, TACI modulates ICOS ligand expression and thereby limits the size of T fh and GC B-cell compartments and prevents autoimmunity. On the other hand, it regulates the survival of ASCs and plays an important role in humoral immunity. |
Author | Ou, Xijun Xu, Shengli Lam, Kong-Peng |
Author_xml | – sequence: 1 givenname: Xijun surname: Ou fullname: Ou, Xijun – sequence: 2 givenname: Shengli surname: Xu fullname: Xu, Shengli – sequence: 3 givenname: Kong-Peng surname: Lam fullname: Lam, Kong-Peng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22949644$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1u1DAUhS1URKeFNSuQJTZlkdZ_SewNUjtlYKSKSnRYW47jTD1ynNRORvRdeNg6zDAFNr6W73eO7vU5AUe-8waAtxidY1TSi96reI4JQpQXGIkXYJZOnBVMoCMwQ4iUGWeEHYOTGDcIIZFz9AocEyKYKBibgV_XprHaGq8fofVw9W3x_W6B6RU8W13Olx-h-dkrX0e4yprOOatHpwK8N643AaYGXJvQWq8c1MYP6e0qXZyLcGtV8tPBqGhquJzf3mXOridFcgwmRtt5WI0DtG2vbIiwdyq26rcaxjFs7Va51-Blo1w0b_b1FPxYfF7Nv2Y3t1-W88ubTLOCD5kuG8KVpkIVmFRICEUNqZkSFUutVCkSmheNKHOtcam1yeta8BKriiVU0FPwaefbj1Vr6mmVoJzsg21VeJSdsvLfjrf3ct1tJWU5pzlNBmd7g9A9jCYOsrVxWkV5041RYsQwJSXFeUI__IduujGkH9xRBBNW8kRd7CgduhiDaQ7DYCSn5OWUvHxOPine_73Dgf8TdQLgHpiUz3ZCUi5xzhBOyLsdsolDFw4MwyUqGC7oE514wUI |
CitedBy_id | crossref_primary_10_3389_fimmu_2017_01338 crossref_primary_10_3389_fimmu_2022_904415 crossref_primary_10_2119_molmed_2016_00022 crossref_primary_10_3389_fimmu_2015_00425 crossref_primary_10_3389_fimmu_2019_02134 crossref_primary_10_1073_pnas_1400539111 crossref_primary_10_3390_ijtm3040031 crossref_primary_10_1177_09612033211062524 crossref_primary_10_3390_cancers12041045 crossref_primary_10_1016_j_bcmd_2016_06_006 crossref_primary_10_1016_j_biopha_2016_10_083 crossref_primary_10_3389_fimmu_2018_03049 crossref_primary_10_1038_s41423_019_0227_z crossref_primary_10_1002_art_37846 crossref_primary_10_1111_age_12533 crossref_primary_10_3389_fphar_2021_621208 crossref_primary_10_1177_09612033221137249 crossref_primary_10_1016_j_isci_2020_101707 crossref_primary_10_1080_14737175_2016_1176531 crossref_primary_10_1155_2015_247426 crossref_primary_10_1016_j_jaci_2015_05_012 crossref_primary_10_3389_fimmu_2021_682334 crossref_primary_10_1172_JCI69854 crossref_primary_10_1080_03009742_2020_1809701 crossref_primary_10_1101_gad_320192_118 crossref_primary_10_1007_s10238_020_00637_0 crossref_primary_10_1016_j_cytogfr_2013_04_003 crossref_primary_10_1016_j_cellimm_2015_02_011 crossref_primary_10_1016_j_celrep_2022_110338 crossref_primary_10_1097_TP_0b013e3182997d34 crossref_primary_10_1016_j_cellimm_2015_01_014 crossref_primary_10_1186_s12916_019_1292_y crossref_primary_10_3389_fonc_2020_00827 crossref_primary_10_1016_j_clim_2017_09_021 crossref_primary_10_1016_j_immuni_2024_02_005 crossref_primary_10_1517_14728222_2014_888415 crossref_primary_10_1172_JCI74428 crossref_primary_10_3892_etm_2019_7172 crossref_primary_10_3389_fimmu_2018_02612 crossref_primary_10_1038_nri3447 crossref_primary_10_1080_1744666X_2017_1291343 crossref_primary_10_1126_sciimmunol_aat7117 crossref_primary_10_1016_j_celrep_2023_112682 crossref_primary_10_1038_srep40133 crossref_primary_10_3390_vaccines8020284 crossref_primary_10_1128_JVI_02904_14 crossref_primary_10_1038_s41598_018_19827_8 crossref_primary_10_1172_jci_insight_136417 crossref_primary_10_3389_fimmu_2023_1235937 crossref_primary_10_1038_s41467_023_37308_z crossref_primary_10_3389_fimmu_2020_00252 crossref_primary_10_3390_ijms24032336 crossref_primary_10_3389_fimmu_2022_873217 crossref_primary_10_1016_j_coi_2021_06_012 crossref_primary_10_1155_2016_5767106 crossref_primary_10_3389_fimmu_2019_00402 crossref_primary_10_1016_j_coi_2021_06_004 crossref_primary_10_4103_ejh_ejh_53_23 crossref_primary_10_4049_jimmunol_1402527 crossref_primary_10_1016_j_cytogfr_2013_12_011 crossref_primary_10_1073_pnas_1323985111 crossref_primary_10_1128_CMR_00046_17 crossref_primary_10_1016_j_celrep_2022_111687 crossref_primary_10_1016_j_clim_2012_10_006 |
Cites_doi | 10.4049/jimmunol.147.12.4126 10.1016/j.immuni.2011.03.023 10.1006/clim.1999.4725 10.1038/ni.1667 10.1016/j.immuni.2011.03.024 10.1073/pnas.1105774108 10.1084/jem.20051283 10.4049/jimmunol.173.4.2331 10.1177/0961203308099176 10.1038/ng1600 10.1146/annurev.immunol.26.021607.090344 10.4049/jimmunol.179.11.7276 10.1182/blood-2007-09-110874 10.1182/blood-2011-05-353961 10.1038/nri2217 10.1016/j.immuni.2008.05.009 10.1038/ng1601 10.4049/jimmunol.180.11.7376 10.1038/45582 10.4049/jimmunol.173.2.807 10.4049/jimmunol.129.6.2698 10.4049/jimmunol.180.8.5222 10.1128/MCB.21.12.4067-4074.2001 10.1038/89790 10.1084/jem.20031330 10.1182/blood-2008-11-189720 10.1016/S1074-7613(01)00130-3 10.1084/jem.20032000 10.1182/blood-2007-05-091306 10.1038/ni.1981 10.1016/j.jaci.2010.08.017 10.1182/blood-2011-05-355412 10.1038/nri2637 10.1146/annurev-immunol-031210-101400 10.1016/j.cytogfr.2008.04.006 10.4049/jimmunol.1102321 10.1182/blood-2002-08-2416 |
ContentType | Journal Article |
Copyright | copyright © 1993-2008 National Academy of Sciences of the United States of America Copyright National Academy of Sciences Sep 18, 2012 |
Copyright_xml | – notice: copyright © 1993-2008 National Academy of Sciences of the United States of America – notice: Copyright National Academy of Sciences Sep 18, 2012 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1073/pnas.1200386109 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | TACI regulates ICOSL and plasma cell survival |
EISSN | 1091-6490 |
EndPage | 15406 |
ExternalDocumentID | 2766198821 10_1073_pnas_1200386109 22949644 109_38_15401 41706416 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X .55 0R~ 123 29P 2AX 2FS 2WC 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACNCT ACPRK ADACV ADULT AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM BKOMP CS3 D0L DCCCD DIK DOOOF DU5 E3Z EBS EJD F5P FRP GX1 H13 HH5 HTVGU HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KQ8 L7B LU7 MVM N9A N~3 O9- OK1 P-O PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VQA W8F WH7 WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ~02 ~KM - 02 0R 1AW 55 AAPBV ABFLS ABPTK ADACO ADZLD AJYGW ASUFR DNJUQ DWIUU DZ F20 KM PQEST X XHC ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c468t-c7f28ac39a612b099a3e2d4a9b4c7f4a9309c86f975cc17cce5dd9871ab4a3e93 |
IEDL.DBID | RPM |
ISSN | 0027-8424 |
IngestDate | Tue Sep 17 21:26:37 EDT 2024 Sat Oct 05 05:35:58 EDT 2024 Thu Oct 10 18:47:13 EDT 2024 Fri Dec 06 01:56:53 EST 2024 Sat Sep 28 08:04:50 EDT 2024 Wed Nov 11 00:30:20 EST 2020 Tue Dec 10 23:06:09 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 38 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c468t-c7f28ac39a612b099a3e2d4a9b4c7f4a9309c86f975cc17cce5dd9871ab4a3e93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: S.X. and K.-P.L. designed research; X.O. performed research; X.O., S.X., and K.-P.L. analyzed data; and X.O. and K.-P.L. wrote the paper. Edited* by Tasuku Honjo, Graduate School of Medicine, Kyoto University, Kyoto, Japan, and approved August 3, 2012 (received for review January 9, 2012) |
OpenAccessLink | https://www.pnas.org/content/pnas/109/38/15401.full.pdf |
PMID | 22949644 |
PQID | 1041212478 |
PQPubID | 42026 |
PageCount | 6 |
ParticipantIDs | pubmed_primary_22949644 jstor_primary_41706416 pnas_primary_109_38_15401 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3458353 proquest_miscellaneous_1041327315 proquest_journals_1041212478 crossref_primary_10_1073_pnas_1200386109 |
ProviderPackageCode | RNA PNE |
PublicationCentury | 2000 |
PublicationDate | 2012-09-18 |
PublicationDateYYYYMMDD | 2012-09-18 |
PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 2012 |
Publisher | National Academy of Sciences National Acad Sciences |
Publisher_xml | – sequence: 0 name: National Academy of Sciences – name: National Acad Sciences – name: National Academy of Sciences |
References | 11359913 - Mol Cell Biol. 2001 Jun;21(12):4067-74 19605846 - Blood. 2009 Sep 10;114(11):2254-62 19935804 - Nat Rev Immunol. 2009 Dec;9(12):845-57 18490737 - J Immunol. 2008 Jun 1;180(11):7376-84 15630136 - J Exp Med. 2005 Jan 3;201(1):35-9 21768353 - Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12827-32 10413651 - Clin Immunol. 1999 Jul;92(1):34-48 18514565 - Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76 18173374 - Annu Rev Immunol. 2008;26:741-66 18599325 - Immunity. 2008 Jul 18;29(1):138-49 22117047 - Blood. 2012 Jan 19;119(3):767-76 18097447 - Nat Rev Immunol. 2008 Jan;8(1):22-33 15240667 - J Immunol. 2004 Jul 15;173(2):807-17 1753088 - J Immunol. 1991 Dec 15;147(12):4126-35 21636296 - Immunity. 2011 Jun 24;34(6):932-46 6982940 - J Immunol. 1982 Dec;129(6):2698-707 21636295 - Immunity. 2011 Jun 24;34(6):947-60 18025170 - J Immunol. 2007 Dec 1;179(11):7276-86 19395451 - Lupus. 2009 May;18(6):501-7 17942754 - Blood. 2008 Feb 1;111(3):1004-12 17720882 - Blood. 2007 Dec 1;110(12):3978-84 22124120 - J Immunol. 2012 Jan 1;188(1):497-503 18978794 - Nat Immunol. 2008 Dec;9(12):1388-98 12714510 - Blood. 2003 Aug 15;102(4):1381-8 14707116 - J Exp Med. 2004 Jan 5;199(1):91-8 11371359 - Immunity. 2001 May;14(5):573-82 16007086 - Nat Genet. 2005 Aug;37(8):829-34 21217761 - Nat Immunol. 2011 Feb;12(2):151-9 10617205 - Nature. 1999 Dec 16;402(6763):827-32 21984806 - Blood. 2011 Nov 24;118(22):5832-9 15294946 - J Immunol. 2004 Aug 15;173(4):2331-41 16007087 - Nat Genet. 2005 Aug;37(8):820-8 21314428 - Annu Rev Immunol. 2011;29:621-63 16301744 - J Exp Med. 2005 Nov 21;202(10):1363-74 18390703 - J Immunol. 2008 Apr 15;180(8):5222-34 20889194 - J Allergy Clin Immunol. 2010 Dec;126(6):1234-41.e2 11429549 - Nat Immunol. 2001 Jul;2(7):638-43 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 Weinstein PD (e_1_3_3_18_2) 1991; 147 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 Butcher EC (e_1_3_3_17_2) 1982; 129 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_1_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – volume: 147 start-page: 4126 year: 1991 ident: e_1_3_3_18_2 article-title: The preference for switching to IgA expression by Peyer’s patch germinal center B cells is likely due to the intrinsic influence of their microenvironment publication-title: J Immunol doi: 10.4049/jimmunol.147.12.4126 contributor: fullname: Weinstein PD – ident: e_1_3_3_20_2 doi: 10.1016/j.immuni.2011.03.023 – ident: e_1_3_3_6_2 doi: 10.1006/clim.1999.4725 – ident: e_1_3_3_19_2 doi: 10.1038/ni.1667 – ident: e_1_3_3_23_2 doi: 10.1016/j.immuni.2011.03.024 – ident: e_1_3_3_27_2 doi: 10.1073/pnas.1105774108 – ident: e_1_3_3_24_2 doi: 10.1084/jem.20051283 – ident: e_1_3_3_2_2 doi: 10.4049/jimmunol.173.4.2331 – ident: e_1_3_3_34_2 doi: 10.1177/0961203308099176 – ident: e_1_3_3_4_2 doi: 10.1038/ng1600 – ident: e_1_3_3_35_2 doi: 10.1146/annurev.immunol.26.021607.090344 – ident: e_1_3_3_13_2 doi: 10.4049/jimmunol.179.11.7276 – ident: e_1_3_3_28_2 doi: 10.1182/blood-2007-09-110874 – ident: e_1_3_3_32_2 doi: 10.1182/blood-2011-05-353961 – ident: e_1_3_3_9_2 doi: 10.1038/nri2217 – ident: e_1_3_3_11_2 doi: 10.1016/j.immuni.2008.05.009 – ident: e_1_3_3_5_2 doi: 10.1038/ng1601 – ident: e_1_3_3_37_2 doi: 10.4049/jimmunol.180.11.7376 – ident: e_1_3_3_33_2 doi: 10.1038/45582 – ident: e_1_3_3_12_2 doi: 10.4049/jimmunol.173.2.807 – volume: 129 start-page: 2698 year: 1982 ident: e_1_3_3_17_2 article-title: Surface phenotype of Peyer’s patch germinal center cells: Implications for the role of germinal centers in B cell differentiation publication-title: J Immunol doi: 10.4049/jimmunol.129.6.2698 contributor: fullname: Butcher EC – ident: e_1_3_3_26_2 doi: 10.4049/jimmunol.180.8.5222 – ident: e_1_3_3_31_2 doi: 10.1128/MCB.21.12.4067-4074.2001 – ident: e_1_3_3_8_2 doi: 10.1038/89790 – ident: e_1_3_3_3_2 doi: 10.1084/jem.20031330 – ident: e_1_3_3_15_2 doi: 10.1182/blood-2008-11-189720 – ident: e_1_3_3_7_2 doi: 10.1016/S1074-7613(01)00130-3 – ident: e_1_3_3_14_2 doi: 10.1084/jem.20032000 – ident: e_1_3_3_25_2 doi: 10.1182/blood-2007-05-091306 – ident: e_1_3_3_30_2 doi: 10.1038/ni.1981 – ident: e_1_3_3_16_2 doi: 10.1016/j.jaci.2010.08.017 – ident: e_1_3_3_21_2 doi: 10.1182/blood-2011-05-355412 – ident: e_1_3_3_36_2 doi: 10.1038/nri2637 – ident: e_1_3_3_10_2 doi: 10.1146/annurev-immunol-031210-101400 – ident: e_1_3_3_1_2 doi: 10.1016/j.cytogfr.2008.04.006 – ident: e_1_3_3_29_2 doi: 10.4049/jimmunol.1102321 – ident: e_1_3_3_22_2 doi: 10.1182/blood-2002-08-2416 |
SSID | ssj0009580 |
Score | 2.397207 |
Snippet | Mutations in TNFRSF13B, better known as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), contribute to common variable... |
SourceID | pubmedcentral proquest crossref pubmed pnas jstor |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 15401 |
SubjectTerms | Animals Antibodies Antigens Autoimmunity B lymphocytes B-Lymphocytes - cytology B-Lymphocytes - immunology Biological Sciences Common variable immunodeficiency Flow Cytometry - methods Gene Expression Regulation Germinal Center - immunology Humans Immune System Inducible T-Cell Co-Stimulator Protein - metabolism Ligands Lymphoid tissue Mice Mice, Inbred C57BL Mice, Transgenic Mutation Plasma Plasma cells Plasma Cells - cytology Receptors, Tumor Necrosis Factor - biosynthesis Rodents Spleen T cell receptors T-Lymphocytes, Helper-Inducer - immunology Transmembrane Activator and CAML Interactor Protein - biosynthesis Transmembrane Activator and CAML Interactor Protein - genetics Up regulation |
Title | Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival |
URI | https://www.jstor.org/stable/41706416 http://www.pnas.org/content/109/38/15401.abstract https://www.ncbi.nlm.nih.gov/pubmed/22949644 https://www.proquest.com/docview/1041212478 https://search.proquest.com/docview/1041327315 https://pubmed.ncbi.nlm.nih.gov/PMC3458353 |
Volume | 109 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwFLa2nbggBgwyxmQkDt0hbWM7cXzcCtWGtIFYJ-0W2Y6zRWqzqGnRfsx-LO85SUcRJ06V4mc3ynsv_l7yvS-EfB7HucwLY8McaxNhHKRUzGyYWii3VCKLxD8auLxKzm_Et9v4dofEfS-MJ-1bUw6r-WJYlfeeW1kv7KjniY1-XE44vuyL-WiX7ML225foG6XdtO07YXD7FUz0ej6Sj-pKN8MI6VgpqoyjEDBTQgEk2NqVWmIiqp2C_b-Q598Eyj92pOkr8rKDkvS0PeV9suOq12S_S9aGDjpF6ZM35OmLQ6EI7LKkZUVnV9Of19OIn9HB7HRycULdY40dv3QWFqjR7amp9N7Na7ekMEDvWsbMnOKZwLEzis_7G_qr1LAe4s7G5fRi8v06nJd3OANWbAm2FTXrFcVezHLZ0Bqw-kL72bRZw10K4vwtuZl-nU3Ow-6zDKEVSboKrSxYqi1XGtCRAYSpuWO50MoIGIJfPlY2TQolY2sjaa2L81xBYaaNAFPFD8he9VC594QyBQhQRkY6FN5yheIcyhdhNePGMMsCMujdktWt-kbm35pLnqFzsmdnBuTAu21jJ1AYCOBmQAJv-jxfZTzNADqOo4Ac9c7NutyFNVGCDGCPTAPyaTMMWYcXR1fuYd3acEB-URyQd20sbP6gj6mAyK0o2Rigovf2CAS6V_buAvvwv2d-IC8A0TEktETpEdlbLdfuI6CmlTnGPSs-9rnyG83PFb0 |
link.rule.ids | 230,314,727,780,784,885,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEF2VcoALaoFS0wKLxCE9OIl3117vsQ1ECTQB0VTqzfKu162lxLXiBPFj-LHM-KsEceJkyTu7tjwz9hv7zTMhH4Z-IpNUGzfB2kRoCynlM-OGBsotFcg0qF4NzObB5Fp8vvFv9ojf9sJUpH2js36-XPXz7K7iVhYrM2h5YoNvsxHHj30-Hzwij30uldcW6Z3Wblh3njC4AQsmWkUfyQdFHpd9DwlZIeqMoxQwU0IBKNh5LtXURNQ7Bft_Yc-_KZR_PJPGB-RZAybpeX3Sh2TP5s_JYZOuJe01mtJnL8ivjxalIrDPkmY5XczH36_GHr-gvcX5aHpG7c8Ce37pwk1Rpbsip9I7uyzsmsIAva05M0uKZwL7Lii-8S_pjyyG9RB5ljah09HXK3eZ3eIMWLGm2OZUbzcUuzGzdUkLQOuruJpNyy3cpyDSX5Lr8afFaOI2P2ZwjQjCjWtkysLYcBUDPtKAMWNuWSJipQUMwZYPlQmDVEnfGE8aY_0kUVCaxVqAqeJHZD-_z-0xoUwBBpSelhalt2yqOIcCRpiYca2ZYQ7ptW6Jilp_I6q-m0seoXOiB2c65KhyW2cnUBoIAKdDnMr0Yb6KeBgBeBx6DjltnRs12QtroggZAB8ZOuR9Nwx5hxcnzu39trbhgP083yGv6ljoDtDGlEPkTpR0BqjpvTsCoV5pezeh_fq_Z74jTyaL2WV0OZ1_OSFPAd8xpLd44SnZ36y39g1gqI1-W2XMbwCqGCw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEF1BkRAX1AIFQ4FF4pAenMS7a6_32KZYDdBQ0VTqzfKu162lxLXipOLH8GOZ8VcbxImTJe_M2vLM2G_st8-EfB77qUwzbdwUexOhLZSUz4wbGmi3VCCzoH41cDYLTi_F1yv_6sGvvmrSvtH5sFgsh0V-U3Mry6UZdTyx0fnZhOPHPp-PyjQbPSZPfA5J1jXqvd5u2Kw-YXATFkx0qj4SvIqkGnpIygpRaxzlgJkSCoDB1rOpoSei5inY_wt__k2jfPBcinbJ8xZQ0qPmxPfII1u8IHttyVZ00OpKH74kv08sykXgWkuaF3Q-i35eRB4_poP50WR6SO2vEtf90rmboVJ3TVClN3ZR2hWFAXrd8GYWFM8E9h1TfOtf0bs8gfkQfVY2pdPJjwt3kV-jB8zY0GwLqjdriisy81VFS0Dsy6T2ptUG7lWQ7a_IZfRlPjl1258zuEYE4do1MmNhYrhKACNpwJkJtywVidIChmDLx8qEQaakb4wnjbF-mipozxItwFTxfbJT3Bb2DaFMAQ6UnpYW5bdspjiHJkaYhHGtmWEOGXRhictGgyOuv51LHmNw4vtgOmS_DltvJ1AeCECnQ5za9N5fxTyMAUCOPYccdMGN2wqGOVGIDMCPDB3yqR-G2sOLkxT2dtPYcMB_nu-Q100u9AfocsohcitLegPU9d4egXSv9b3b9H77354fydPzkyj-Pp19e0eeAcRjyHDxwgOys15t7HuAUWv9oS6YPwmWGT8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deficiency+in+TNFRSF13B+%28TACI%29+expands+T-follicular+helper+and+germinal+center+B+cells+via+increased+ICOS-ligand+expression+but+impairs+plasma+cell+survival&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Ou%2C+Xijun&rft.au=Xu%2C+Shengli&rft.au=Lam%2C+Kong-Peng&rft.date=2012-09-18&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=109&rft.issue=38&rft.spage=15401&rft.epage=15406&rft_id=info:doi/10.1073%2Fpnas.1200386109&rft.externalDBID=n%2Fa&rft.externalDocID=10_1073_pnas_1200386109 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F38.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F38.cover.gif |